Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

Pharmaceutical Executive January 1, 2007 Glass & Poli	Forecast 2007: Connecting the Dots How do execs rank the issues facing the pharmaceutical industry? And what are the links they see between them? A new study reveals the industry's mental map of today's challenges.
Pharmaceutical Executive September 1, 2012 Roy F. Waldron	Open Innovation in Pharma: Defining the Dialogue There is much talk today about "open innovation" in business and research forums, but what exactly does it mean? How does open innovation as a concept apply to the pharmaceutical sector?
Pharmaceutical Executive September 1, 2010	Explaining the Drug Drought Industry needs to engage in a broader public debate on ways to rekindle the innovative engine in new drug discovery and development.
BusinessWeek September 17, 2009	Regulating Financial Innovation: Three Views Economists and policymakers are divided over the right way to regulate innovative consumer financial products. Here are the three main perspectives.
Pharmaceutical Executive June 1, 2012 Ben Comer	Disruption in the C-Suite Clayton Christensen, author of "The Innovator's Dilemma," offers to collaborate with pharma CEOs on solutions to the strategic impasse around flagging drug productivity.
Pharmaceutical Executive January 21, 2014 Tim Powell	Innovation: The Moneyball Test Successful innovation now has to align with key metrics of value; can an old baseball metaphor help guide the way?
Pharmaceutical Executive August 1, 2011 Bill Drummy	The Slow Dance Toward Obsolescence Does Big Pharma have the emotional connection and intellectual commitment to move with the pace of change?
Fast Company April 2008	Making Innovation Work Approaching innovation systematically and being ruthless about the allocation of resources to it are keys to a successful business. Here are some simple mistakes made by companies that muffled innovation.
Pharmaceutical Executive November 1, 2011 Josef Bossart	Pharma Revolution Recalibrated Industry critics point to a lag in NME approvals as proof of innovation stagnation, but combination products and new delivery systems are quietly saving lives, and bringing in big dollars.
CIO August 15, 2001 Sandy kendall	How Things Change Five top gurus' views on innovation principles and practices...
Pharmaceutical Executive July 1, 2013 Richie Etwaru	Innovation Calls Across the C-suite: Lessons From Wall Street The lifeblood of the life sciences industry is continuous innovation; it is not a business that can survive by standing still.
CRM January 2010 Joshua Weinberger	CRM on Twitter: January 2010 The definition of innovation... Costs of innovation... How to measure innovation... Open innovation... etc.
Bio-IT World December 10, 2002 Malorye Branca	The Trouble with Pharmaceutical Innovation There's a lot of one kind, but not enough of another in pharma land. Too many new technologies and too few new drugs -- that sums up the state of pharmaceutical R&D.
CIO August 29, 2011 Weiss & Drewry	How Collaboration Enables Affordable Innovation Top companies are turning to crowd sourcing on public and private networks to pave the way to more affordable idea creation.
BusinessWeek April 15, 2010 James P. Andrew	What Executives Make of Innovation The head of the global innovation practice at Boston Consulting Group dives more deeply into the findings from this year's survey taken to compile the ranking of the most innovative companies.
CFO February 1, 2012 Marielle Segarra	Forging Ahead: How to Get Innovation Right Be willing to endure some growing pains, says an innovation guru.
Pharmaceutical Executive April 1, 2007 Walter Armstrong	Make It New To fix pharma's business model, nothing less than big, bold, and risky fits the bill. Two radical new visions focus on getting back to the roots of innovation -- and letting a thousand flowers bloom.
IndustryWeek January 31, 2012 Josh Cable	GE Barometer: Executives Believe Innovation and Growth Go Hand-in-Hand However, uncertainty in the global economy is curbing their companies' appetites for risk and making it harder for them to find capital.
CIO December 23, 2008 Jarina D'Auria	Five Things Judy Estrin Has Learned About Closing the Innovation Gap In her book, Closing the Innovation Gap, former Cisco CTO Judy Estrin shares why CIOs and other leaders must nurture innovation to fend off global competition.
Pharmaceutical Executive December 1, 2011 George Baeder	China's Future in Bioscience Will big investments in infrastructure carry the day in positioning China as a global drug innovation powerhouse?
Pharmaceutical Executive December 1, 2006 Ragnar Lofstedt	Back Page: The Post-Trust World People no longer put their faith in industry or regulators. What can we do about that? A good start would be understanding the human side of risk.
BusinessWeek November 17, 2003 Samuel J. Palmisano	How The U.S. Can Keep Its Innovation Edge Where, how, and why innovation happens is changing. If we're not careful, the U.S. will fall out of step with these new realities, and innovators and risk-takers will go elsewhere -- because they can.
IndustryWeek November 18, 2009 Jill Jusko	Improve Your Innovation Pipeline External collaboration and improved portfolio management are among the strategies for success.
Pharmaceutical Executive July 3, 2007 Walter Armstrong	Take Me to Your Leader Turnover in the top 10 pharmas has new CEOs racing to reinvent the way their companies do business. Running a large pharmaceutical company has becoming immensely complex, and requires a broad set of management skills. Even then, a CEO may never see a beloved molecule approved for drughood.
Bio-IT World September 2006 Kevin Davies	The $2 Billion Pill? Challenges and opportunities facing the drug industry were recurring themes in the quartet of keynote speeches at the 2006 Drug Discovery Technology conference.
Bank Systems & Technology March 29, 2006 Katherine Burger	You're Wearing That? Innovation is not just about new products and services, but also encompasses business model innovation, process innovation, culture innovation and management system innovation.
Pharmaceutical Executive January 1, 2011	The Steep, Slow Climb A survey of leading experts reveals 2011's sobering reality and the trends that smart drugmakers will follow into the next decade.
CIO December 1, 2006 Gary Beach	Employee Power Where will 2007's innovative ideas come from? You need look no further than your own backyard.
Pharmaceutical Executive October 1, 2011 Jill Wechsler	Guiding a Revolution in Science Francis Collins led the genomic revolution as director of the International Human Genome Project and director of the National Human Genome Research Institute (NHGRI) at the NIH from 1993 to 2008.
The Motley Fool March 23, 2011 Brian Orelli	Eli Lilly: Great Plan, Poor Execution Eli Lilly shuns large mergers, but hasn't produced drugs on its own.
Pharmaceutical Executive September 1, 2011 Richard Barker	Innovating Around Innovation The former Director General of ABPI, proposes a new agenda on how to restore public confidence in the value behind science.
Entrepreneur September 2002 Katherine Catlin	Practice Makes Perfect Introducing the top innovators of 1989. As you would imagine, they've done a lot more innovating in the meantime.
BusinessWeek June 3, 2009 Michael Mandel	The Failed Promise of Innovation in the U.S. During the past decade, innovation has stumbled. And that may help explain America's economic woes.
IndustryWeek February 17, 2010 Josh Cable	Building an Innovation Culture For innovation to flourish, executives must be committed, patient and ready to lead by example.
The Motley Fool August 23, 2004 Ben McClure	Rethinking Big Pharma Risk is knocking Big Pharma stocks down. They won't be getting up anytime soon. Competition, soaring R&D costs, shifting business models, and political meddling combine to make drug stocks a riskier place to invest.
Pharmaceutical Executive January 1, 2007 Walter Armstrong	Forecast 2007: At Sea In times of crisis, it's harder than ever to take the long view. The healing arts may be as old as humankind, but the business of pharma is still in its infancy.
HBS Working Knowledge August 9, 2010 Julia Hanna	How to Speed Up Energy Innovation In her book, Accelerating Innovation in Energy: Insights from Multiple Sectors, Rebecca Henderson explores the histories of innovation in four sectors of the U.S. economy
Pharmaceutical Executive November 1, 2008 Joanna Breitstein	Gilding Lilly With new CEO John Lechleiter in charge, can Lilly find its way back from the edge?
CIO February 25, 2009 Diann Daniel	Guy Kawasaki on Innovation and the Myth of Lightning-Bolt Inspiration Power Twitter user, former Mac evangelist, and Alltop cofounder Guy Kawasaki knows a thing or two about innovation.
The Motley Fool September 9, 2004 Charly Travers	The Case for Drug Stocks The reports of the drug industry's death are greatly exaggerated.
Pharmaceutical Executive January 1, 2012 Jill Wechsler	New Year, New Issues Look for action in 2012 on drug access, shortages, innovation, and transparency. The 800-pound gorilla in the room is the looming Supreme Court decision on the constitutionality of the Obama health reform legislation.
CIO November 15, 2005 Michael Schrage	Innovation Alchemy One of the most important things CIOs can create is the right mix of healthy environment and reliable process in order to foster innovation.
Pharmaceutical Executive October 1, 2011 Atsushi Nagahisa	Creating Customer Value: It's No Distant Dream The author speaks about how the pharmaceutical industry can fix today's greatest global policy challenge: leveraging hard science to address an enormous -- and growing -- burden of unmet medical need.
CRM March 17, 2014 Maria Minsker	CIOs Are Pushing for More Innovation, Constellation Research Finds As CIOs embrace new responsibilities, a chief digital officer role may emerge in the c-suite.
InternetNews March 6, 2009 David Needle	Confronting the 'Tech Innovation Deficit' Microsoft R&D exec Rick Rashid and others debate the challenge of promoting innovation in a down economy.
IndustryWeek October 20, 2010	Innovation Nation? Manufacturers are more involved than other industries in innovation, but engagement is hardly widespread.
Pharmaceutical Executive October 1, 2005 Brad Miles	Value Today for Drugs Tomorrow The industry can help its bad rep by communicating the promise of its pipeline -- and the value of its companies.
Fast Company Rose Pastore	10 Companies Every Entrepreneur Should Know Take the test below to learn more about what the world's most innovative businesses are doing right.
Pharmaceutical Executive April 1, 2011	The Big Business of Boosting Performance Dutch-based DSM N.V. is seeking innovative ways to partner through bolstering manufacturing.
Wall Street & Technology June 16, 2006 Bob Violino	Top-Down Innovation CEOs have another - and an increasingly urgent - assignment to add to their leadership portfolios: driving innovation and tearing down barriers that may prevent it. Technology is playing a large part in new business models.